What sets your company apart, and how does your process differ from other patient education companies?

PRIMR’s approach to ensuring low-risk content approval by IRBs involves rigorous processes and adherence to regulatory standards.

With a track record of 100% IRB approval on first submission for our content over 4 years, PRIMR demonstrates its commitment to compliance and quality assurance.

PRIMR employs thorough review processes, collaboration with key opinion leaders in our network, and adherence to industry best practices to achieve consistent approval rates. Other content vendors lack oncology expertise, outsource expert review, slowing down the process, increasing costs and lowering the ultimate quality of the product and impact on patient understanding.